Nuclear hormone receptor co-repressors
- PMID: 15860250
- DOI: 10.1016/j.jsbmb.2004.12.012
Nuclear hormone receptor co-repressors
Abstract
Gene silencing is an essential transcriptional regulatory process. Co-repressors mediate gene repression through their recruitment by DNA bound transcriptional silencer proteins. Co-repressors repress gene expression through several mechanisms, mostly investigated on the level of chromatin. Lack or aberrant gene silencing is associated with many defects both on cellular and organismic level. Several human diseases are based on dysregulated co-repressor binding to transcriptional silencers indicating that co-repressor recruitment and the strength of gene silencing must be under strict control. In line with that gene silencing is important for animal development, cellular proliferation and transformation. Co-repressors play also a major role in the treatment of hormone-dependent growing cancers, such as for breast and prostate cancer therapy. The molecular basis of anti-hormone therapy lies in the recruitment of co-repressors to the estrogen or androgen receptors, respectively, which leads to their inactivation and to inhibition of cancer growth. The molecular mechanisms of selected topics are summarized here.
Similar articles
-
Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):191-200. doi: 10.1016/j.jsbmb.2004.12.002. Epub 2005 Jan 28. J Steroid Biochem Mol Biol. 2005. PMID: 15860262
-
Co-repressors 2000.FASEB J. 2000 Oct;14(13):1876-88. doi: 10.1096/fj.99-0943rev. FASEB J. 2000. PMID: 11023972 Review.
-
Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.J Mol Endocrinol. 2009 May;42(5):429-35. doi: 10.1677/JME-08-0084. Epub 2009 Feb 17. J Mol Endocrinol. 2009. PMID: 19223455
-
Analysis of ligand-specific co-repressor binding to the androgen receptor.Methods Mol Biol. 2011;776:199-223. doi: 10.1007/978-1-61779-243-4_13. Methods Mol Biol. 2011. PMID: 21796529
-
Gene silencing by the thyroid hormone receptor.Mol Cell Endocrinol. 2003 Dec 31;213(1):13-22. doi: 10.1016/j.mce.2003.10.026. Mol Cell Endocrinol. 2003. PMID: 15062570 Review.
Cited by
-
A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression.EMBO J. 2007 Jan 10;26(1):65-75. doi: 10.1038/sj.emboj.7601483. Epub 2006 Dec 14. EMBO J. 2007. PMID: 17170703 Free PMC article.
-
A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.J Mol Med (Berl). 2016 Oct;94(10):1167-1179. doi: 10.1007/s00109-016-1440-1. Epub 2016 Jun 16. J Mol Med (Berl). 2016. PMID: 27305909
-
Interrelation of androgen receptor and miR-30a and miR-30a function in ER-, PR-, AR+ MDA-MB-453 breast cancer cells.Oncol Lett. 2017 Oct;14(4):4930-4936. doi: 10.3892/ol.2017.6781. Epub 2017 Aug 21. Oncol Lett. 2017. PMID: 29085503 Free PMC article.
-
Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing.Mol Endocrinol. 2007 Aug;21(8):1924-39. doi: 10.1210/me.2007-0035. Epub 2007 May 22. Mol Endocrinol. 2007. PMID: 17519355 Free PMC article.
-
Chaperone-mediated autophagy substrate proteins in cancer.Oncotarget. 2017 May 3;8(31):51970-51985. doi: 10.18632/oncotarget.17583. eCollection 2017 Aug 1. Oncotarget. 2017. PMID: 28881704 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical